Lexicon Pharmaceuticals | Srodki Pieniężne I Ekwiwalent

Cena Akcji
1.31
Dzienna Zmiana
0 0%
Miesięcznie
5.65%
Rocznie
66.90%
Q1 Prognozy TE
2.01




Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 7.51B 560M 2025-09
Acadia Pharmaceuticals USD 847.02M 85.02M 2025-09
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Akebia Therapeutics USD 166.44M 29.14M 2025-09
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
Coherus Biosciences USD 103.35M 113.54M 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Halozyme Therapeutics USD 419.66M 357.8M 2025-09
Illumina USD 1.42B 368M 2025-12
Insmed USD 334.76M 949.56M 2025-09
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
J&J USD 19.71B 1.48B 2025-12
Lexicon Pharmaceuticals USD 21.36M 41.52M 2025-06
MacroGenics USD 80.13M 50.56M 2025-09
MannKind USD 127.39M 70.39M 2025-09
Merck USD 18.17B 10.16B 2025-09
Moderna USD 2.6B 1.46B 2025-12
Novartis USD 9.56B 2.9B 2025-09
PTC Therapeutics USD 672.62M 344.77M 2025-09
Puma Biotechnology USD 53.52M 1.14M 2025-09
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
United Therapeutics USD 1.34B 253M 2025-09
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12


Lexicon Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.